Guanfacine for irritability, impulsivity, and agitation in elderly patients: A report of two cases.
agitation
elderly patients
guanfacine
impulsivity
irritability
Journal
PCN reports : psychiatry and clinical neurosciences
ISSN: 2769-2558
Titre abrégé: PCN Rep
Pays: Australia
ID NLM: 9918451287106676
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
28
01
2022
revised:
19
03
2022
accepted:
23
03
2022
medline:
18
5
2022
pubmed:
18
5
2022
entrez:
13
6
2024
Statut:
epublish
Résumé
Irritability, impulsivity, and agitation in elderly patients with dementia are highly prevalent and extremely burdening for patients, caregivers, and medical staff. In general hospitals, they have been one of the major problems that develop and disturb care and treatment. However, the mechanisms underlying these symptoms remain unclear, and there is no established treatment. In actual clinical practice, antipsychotic drugs and mood stabilizers have been mainly used as pharmacotherapies for these symptoms, but adverse effects of these drugs have often been problematic. We report two valuable cases of elderly patients who were admitted to our hospital due to physical disorders and developed irritability, impulsivity, and agitation, which were effectively treated with guanfacine at very low doses and in a short period. The present cases suggest that guanfacine may be a therapeutic option for treating irritability, impulsivity, and agitation in elderly patients.
Sections du résumé
Background
UNASSIGNED
Irritability, impulsivity, and agitation in elderly patients with dementia are highly prevalent and extremely burdening for patients, caregivers, and medical staff. In general hospitals, they have been one of the major problems that develop and disturb care and treatment. However, the mechanisms underlying these symptoms remain unclear, and there is no established treatment. In actual clinical practice, antipsychotic drugs and mood stabilizers have been mainly used as pharmacotherapies for these symptoms, but adverse effects of these drugs have often been problematic.
Case Presentation
UNASSIGNED
We report two valuable cases of elderly patients who were admitted to our hospital due to physical disorders and developed irritability, impulsivity, and agitation, which were effectively treated with guanfacine at very low doses and in a short period.
Conclusion
UNASSIGNED
The present cases suggest that guanfacine may be a therapeutic option for treating irritability, impulsivity, and agitation in elderly patients.
Identifiants
pubmed: 38868640
doi: 10.1002/pcn5.14
pii: PCN514
pmc: PMC11114348
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
e14Informations de copyright
© 2022 The Authors. Psychiatry and Clinical Neurosciences Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.